NCT05896176

Brief Summary

To be able to diagnose obstructive sleep apnea syndrome (OSAS) in a patient, polysomnography (PSG) remains the gold standard. However, this is expensive, involves a considerable workload and is quite complex. Additionally, the wait time from when the patient was referred for PSG to when it is done can take up to 5-6 months. Simpler screening tools have therefore been developed, such as questionnaires. The questionnaires are subjective tools completed by the parents based on the observation of the child's sleep, behavioral problems, etc. These questionnaires have shown usefulness in sorting out patients to be referred to a sleep specialist, an Oto-Rhino-Laryngologist (ENT) or an orthodontist before performing a PSG in view of the difficulty of access to it. The Pediatric Sleep Questionnaire (PSQ) is a tool that was developed by Chervin and his colleagues to screen children with OSAS. This questionnaire is a reliable and scientifically validated tool. In addition, the PSQ is the most accurate questionnaire from a screening point of view. However, the American Academy of Pediatric Dentistry (AAPD) considers that the questionnaires, among others, the PSQ, are not sensitive enough to detect OSAS in a child. They offer an anamnesis as well as a clinical examination to be carried out in addition to the few questions taken from the PSQ that they consider useful for screening patients at risk. The investigators can therefore ask themselves the following question: "Is the PSQ sufficient on its own or do the investigators obtain better results when the investigators carry out a complete anamnesis as well as a clinical examination? "

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 9, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 9, 2023

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

June 9, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

April 10, 2023

Last Update Submit

May 29, 2023

Conditions

Keywords

child

Outcome Measures

Primary Outcomes (2)

  • PSQ + or -

    Patient positive or negative on Pediatric Sleep Questionnaire (PSQ)

    The data collection is carried out during the consultation

  • History/clinical examination + or -

    Patient positive or negative at History/clinical examination

    The data collection is carried out during the consultation

Study Arms (2)

Pediatric Sleep Questionnaire (PSQ) +

Patient who obtained a score of 7 or more on the PSQ

Diagnostic Test: a clinical examination and anamnesis

Pediatric Sleep Questionnaire (PSQ) -

Patient who obtained a PSQ score less than 7

Interventions

The investigators compare the results of the PSQ alone with the elements provided by the clinical examination regarding the referral of patients to the Otolaryngologist (ENT) consultation.

Pediatric Sleep Questionnaire (PSQ) +

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients between 2 and 8 years old presenting to the pediatric dentistry consultation at Erasmus Hospital,EMC site, speaking French and agreeing to participate in the study

You may qualify if:

  • \- 2-8 years

You may not qualify if:

  • Patients who do not speak French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tania Vanhée

Brussels, 1000, Belgium

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Immunologic Memory

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Adaptive ImmunityImmunityImmune System Phenomena

Study Officials

  • Fairouz Ben Abdelouahed

    Directrice du service de Dentisterie HUB

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Astrid Vanden Abbeele

CONTACT

Tania Vanhée

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

April 10, 2023

First Posted

June 9, 2023

Study Start

December 9, 2022

Primary Completion

March 31, 2023

Study Completion

July 1, 2023

Last Updated

June 9, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations